All 3 insiders bought on Nov 2 — a single shared event.
- Ra Capital Management,…Director, 10% Owner$46.6M
- Jeggle Helmut WolfgangDirector, 10% Owner$6M
- Salvia Investment GmbH10% Owner$6M
Insider trading activity for Bambusa Therapeutics, Inc., straight from SEC Form 4 filings. Net figures below count open-market buys and sales only — grants, option exercises and tax withholding are excluded because they are compensation, not decisions to trade.
3 insiders bought on the open market within 30 days.
All 3 insiders bought on Nov 2 — a single shared event.
The 30 most recent Form 4 transactions.
How quickly insiders here report their trades. Section 16 allows two business days from the transaction.
All 5 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
Everyone who has filed a Form 4 for this issuer.
Other issuers in the same industry with insider filings on record.